[PLX] YoY Quarter Result on 30-Jun-2009 [#Q2]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
03-Aug-2009
Financial Year
2009
Quarter
30-Jun-2009 [#Q2]
Profit Trend
QoQ- -4.71%
YoY- -28.33%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 CAGR
Revenue 26,113 764 1,141 0 0 0 0 -
PBT 22 179 0 0 0 -13,110 29 -4.49%
Tax -8,765 20,699 -109 -446 -669 -512 -7 227.94%
NP 9,642 -13,689 -10,041 -5,427 -4,229 -12,604 29 162.97%
Tax Rate 39,840.91% -11,563.69% - - - - 24.26% -
Total Cost 16,471 14,453 11,182 5,427 4,229 12,604 -29 -
Ratio Analysis
30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 CAGR
NP Margin 36.92 -1,791.75 -880.02 0.00 0.00 0.00 0.00 -
Per Share
30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 CAGR
EPS 0.11 -0.16 -0.12 -0.07 -0.06 -1.92 -0.10 -
EPS Diluted 0.10 -0.16 -0.12 -0.07 -0.06 -1.92 -0.10 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.